{"id":"NCT01405053","sponsor":"Eisai Inc.","briefTitle":"Study of Rufinamide in Pediatric Subjects 1 to Less Than 4 Years of Age With Lennox-Gastaut Syndrome Inadequately Controlled With Other Anti-epileptic Drugs","officialTitle":"A Multicenter, Randomized, Controlled, Open-label Study to Evaluate the Cognitive Development Effects and Safety, and Pharmacokinetics of Adjunctive Rufinamide Treatment in Pediatric Subjects 1 to Less Than 4 Years of Age With Inadequately Controlled Lennox-Gastaut Syndrome","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-06-16","primaryCompletion":"2015-11-02","completion":"2015-11-02","firstPosted":"2011-07-29","resultsPosted":"2019-08-06","lastUpdate":"2019-08-06"},"enrollment":37,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Lennox-Gastaut Syndrome"],"interventions":[{"type":"DRUG","name":"Rufinamide","otherNames":[]},{"type":"DRUG","name":"Any other approved Antiepileptic Drug","otherNames":[]}],"arms":[{"label":"Rufinamide","type":"ACTIVE_COMPARATOR"},{"label":"Any other approved AED","type":"ACTIVE_COMPARATOR"}],"summary":"This study was designed to evaluate the cognitive effect, safety, and pharmacokinetics (PK) of rufinamide on Lennox-Gastaut Syndrome (LGS) inadequately controlled in pediatric participants already taking other anti-epileptic drugs.","primaryOutcome":{"measure":"Child Behavior Checklist (CBCL) Total Problem T-scores at the End of 2-year Treatment Period","timeFrame":"End of Treatment Period (up to approximately Week 106)","effectByArm":[{"arm":"Rufinamide","deltaMin":55.7,"sd":15.81},{"arm":"Any Other Approved Antiepileptic Drug","deltaMin":54.8,"sd":4.5}],"pValues":[{"comp":"OG000 vs OG001","p":"0.6928"}]},"eligibility":{"minAge":"1 Year","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":47,"countries":["United States","Canada","France","Greece","Italy","Poland","South Africa"]},"refs":{"pmids":["33825230","31168494","30309816","26805435"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":10,"n":25},"commonTop":["Upper respiratory tract infection","Vomiting","Diarrhoea","Pyrexia","Cough"]}}